MedTrace Logo

Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas

NCT02125669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-04-29

No results posted yet for this study

Summary

Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking due to inconsistent design of available studies. The purpose of this study is to evaluate the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low risk anatomical sites in an evidence based study setting.

Conditions

Interventions

PROCEDURE

Laser treatment

Pulsed dye laser 595nm

DEVICE

SHAM-Treatment

using the pulsed dye laser (PDL) laser without releasing a pulse

Sponsors & Collaborators

  • University Medicine Greifswald

    collaborator OTHER

  • Hautklinik Darmstadt

    lead OTHER

Principal Investigators

  • Maurizio Podda, Dr. · Hautklinik Darmstadt

  • Syrus Karsai, Dr. · Hautklinik Darmstadt

  • Heiko Friedl · Hautklinik Darmstadt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02125669 on ClinicalTrials.gov